Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Relationship of Cytokine Production and Immune Responses to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine
Authors not listed
Columbia University · 2011
Abstract
After immunization, particularly in older persons, some people are protected from disease by a vaccine and others are not. The investigators believe that this variable response may be due to overproduction of molecules that suppress development of immunity (antibodies and cell mediated immunity). Normally, these molecules are produced to make sure that immunity is regulated in just the right way for the body as a whole, and to prevent autoimmune disease.
However, with aging, the immune system may have difficulty in proper immune regulation. Over production of immunosuppressive molecules after vaccination may interfere with the effects of a vaccine. For example when elderly individuals are immunized against zoster with a licensed vaccine, Zostavax, the vaccine is effective in only about 50 to 60%. The investigators will compare blood levels of antibodies, cellular immunity, and immunosuppressive molecules in recipients of Zostavax to see if there is a correlation between development low immunity and high levels of immunosuppressive molecules.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Anonymous. (2011). Relationship of Cytokine Production and Immune Responses to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine. <em>Columbia University</em>. https://clinicaltrials.gov/study/NCT01288014
Vancouver
Anonymous. Relationship of Cytokine Production and Immune Responses to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine. Columbia University. 2011.
BibTeX
@misc{anon2011Relati,
title = {Relationship of Cytokine Production and Immune Responses to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine},
author = {Anonymous},
journal = {Columbia University},
year = {2011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Changchun Zhuoyi Biological Co., Ltd 2019
Open access · US-GOV
Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)
Sanofi Pasteur, a Sanofi Company 2007
Open access · US-GOV
Evaluation of the Cellular, Humoral and Mucosal Immune Response in Adults and Elderly Subjects Vaccinated Either With an Inactivated Influenza Vaccine Administered Via the Intradermal Route or an Inactivated Influenza Vaccine Administered Via the Intramuscular Route
Seminars in Immunology 2023
Preprint · OA
Immune aging – A mechanism in autoimmune disease
Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021
Open access · OA
Muscle specific aging signature of PDGFRα-positive stromal cells underlies the development of age-related sarcopenia
Frontiers in Immunology 2022
Open access · CC-BY
Immune system modulation in aging: Molecular mechanisms and therapeutic targets
Alachua Government Services, Inc. 2009
Open access · US-GOV